Literature DB >> 29753023

Reduced left ventricular mechanical dispersion at 6 months follow-up after cardiac resynchronization therapy is associated with superior long-term outcome.

Pieter van der Bijl1, Mand J H Khidir1, Melissa Leung1, Dilek Yilmaz1, Bart Mertens2, Nina Ajmone Marsan1, Victoria Delgado1, Jeroen J Bax3.   

Abstract

BACKGROUND: In heart failure (HF) patients, left ventricular mechanical dispersion (LVMD) reflects heterogeneous mechanical activation of the left ventricle. In HF patients, LVMD can be reduced after CRT. Whether lesser LVMD is associated with improved outcome is unknown.
OBJECTIVE: The purpose of this study was to relate LVMD to long-term prognosis in a large cohort of HF patients after 6 months of cardiac resynchronization therapy (CRT).
METHODS: Clinical, echocardiographic, and ventricular arrhythmia (VA) data were analyzed from an ongoing registry of HF recipients of CRT. Baseline (before CRT) and 6-month echocardiograms were evaluated. LVMD was calculated as the standard deviation of the time from onset of the QRS complex to the peak longitudinal strain in a 17-segment model. Patients were divided into 2 groups according to the median LVMD (84 ms) at 6 months post-CRT.
RESULTS: Of 1185 patients (mean age 65 ± 10 years; 76% male), 343 (29%) died during a mean follow-up of 55 ± 36 months. Baseline LVMD was not associated with all-cause mortality and VA at follow-up. In contrast, patients with less LVMD (≤84 ms) at 6 months post-CRT had lower event rates (VA and mortality) compared to those with LVMD >84 ms. On multivariable analysis, greater LVMD at 6 months after CRT was independently associated with an increased risk of mortality (hazard ratio 1.002; P = .037) and VA (hazard ratio 1.003; P = .026).
CONCLUSION: Larger LVMD at 6 months after CRT is independently associated with all-cause mortality and VA. LVMD may be valuable in identifying patients who remain at high mortality risk after CRT implantation.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Heart failure; Mechanical dispersion; Prognosis; Speckle tracking

Mesh:

Year:  2018        PMID: 29753023     DOI: 10.1016/j.hrthm.2018.05.005

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  3 in total

1.  Cardiac Resynchronization Therapy Response Assessment with Electromechanical Activation Mapping within 24 Hours of Device Implantation: A Pilot Study.

Authors:  Lea Melki; Daniel Y Wang; Christopher S Grubb; Rachel Weber; Angelo Biviano; Elaine Y Wan; Hasan Garan; Elisa E Konofagou
Journal:  J Am Soc Echocardiogr       Date:  2021-03-04       Impact factor: 7.722

2.  Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review.

Authors:  Vinesh Appadurai; Nicholas D'Elia; Thomas Mew; Stephen Tomlinson; Jonathan Chan; Christian Hamilton-Craig; Gregory M Scalia
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-31

Review 3.  Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.

Authors:  Issa Pour-Ghaz; Mark Heckle; Ikechukwu Ifedili; Sharif Kayali; Christopher Nance; Rajesh Kabra; Sunil K Jha; John L Jefferies; Yehoshua C Levine
Journal:  Curr Cardiol Rev       Date:  2022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.